Kedalion Therapeutics

Kedalion Therapeutics is a venture-backed, clinical-stage biotechnology company with the mission of bringing transformative topical ophthalmic therapies to market for both new and existing indications. Kedalion's proprietary AcuStream™ platform technology delivers topical medications to the eye in a precise and accurate manner, achieving comparable efficacy to standard eye drops while reducing the dosage by up to 80%, thereby minimizing side effects and enhancing patient comfort.